With $275M in New NIH Funding, TCGA to Study More than 20 Cancers over Next Two Years | GenomeWeb

By Julia Karow

This article, originally published Sept. 30, has been updated with comments from an NHGRI official.

The Cancer Genome Atlas has received $275 million in new funding from the National Institutes of Health — including about $125 million allocated for sequencing — to study more than 20 types of cancer over the next two years. Within the next five years, the project plans to generate comprehensive genomic maps for these cancers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Through a transcriptome study, researchers home in on the activity of inflammation-linked genes in chronically lonely people.

Determining who is and is not an author and where a researcher should fall on a list of authors can be a tricky task, Nature News writes.

In PNAS this week: variant protective against Alzheimer's disease, effect of whole-genome duplication on methylation in rice, and more.

Genome editing is also bringing up questions when applied to farm animals, the New York Times reports.